Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells

求助中 10 由钱钱发布于 2026/2/6 17:44:58

DOI:10.1126/scitranslmed.adr9382
作者：Ivan J. Cohen, Audrey C. Bochi-Layec, Jean Lemoine, Scott Jenks, Pedram Bayat, Ki Hyun Kim, Huiwu Zhao, Ositadimma Ugwuanyi, Federico Stella, Guido Ghilard
文献类型：期刊论文
补充材料：只需要正文

American Association for the Advancement of Science (AAAS)

Abstract：Current US Food and Drug Administration–approved chimeric antigen receptor (CAR) T cell therapies for B cell leukemias and lymphomas target CD19, which is widely expressed across the B cell

应助信息

等您来应助

上传文件

3小时前

Book学术机器人

2026/2/6 17:44:58 未找到该文献，机器人已退出，请等待人工下载

2026/2/6 17:44:58 Book学术AI机器人收到请求，开始寻找文献

2026/2/6 17:44:58 已向机器人发送请求

3小时前

钱钱发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:Inderscience PublishersHow do short video content characteristics influence short video app addiction An affective response perspective